FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949585417> ?p ?o ?g. }

• W2949585417 abstract "Background: Tenosynovitis (TS) is a common, often clinically undetectable finding in Rheumatoid Arthritis (RA). Recent data showed TS on ultrasound (US) has a role in predicting outcome in early disease and flare in clinical remission. However data is limited on US measured TS in healthy subjects (HS), none specifically encompassing the older age range when RA commonly presents. Objectives: This OMERACT study aimed to determine prevalence of US measured tendon abnormalities in HS throughout the age range. Methods: Adult HS without: joint pain (VAS A comparison cohort of DMARD-naive patients with RA (ACR-EULAR 2010 and/or 1987 criteria) at presentation was taken from the Birmingham Early Arthritis (BEACON) inception cohort, who underwent identical tendon US assessment. They were grouped into ≤12 and > 12 weeks from symptom onset. Results: Data from 899 HS and 144 RA patients were included. Prevalence of TSH and particularly PD abnormalities in HS was very low at all ages, and was all grade 1 except in one individual ECU tendon. ECU TSH grade≥1 was more common than DF grade≥1 in the older HS groups, and less common in the 18-39 age group (p=0.011). TSH and PD of grade ≥1 were common in RA patients, with DF PD abnormalities more common in early disease (p=0.02). Conclusion: Low prevalence of TSH or PD abnormalities in tendons of HS even in old age suggests US determined TS will be a robust tool in clinically managing RA. References: [1] Naredo E, D’Agostino MA, et al. Reliability consensus-based US score TS RA. ARD.2013;72(8):1328-34 Disclosure of Interests: Jeanette Trickey: None declared, Ilfita Sahbudin: None declared, Alessandra Bortoluzzi: None declared, Annamaria Iagnocco: None declared, Carlos Pineda: None declared, Cesar Sifuentes-Cantu: None declared, Coziana Ciurtin: None declared, Cristina Reategui Sokolova: None declared, Daniela Fodor: None declared, Ellen-Margrethe Hauge: None declared, Esperanza Naredo Consultant for: Abbvie, Speakers bureau: AbbVie, Roche, Bristol-Myers Squibb, Pfizer, UCB, Lilly, Novartis, Janssen, and Celgene GmbH, Florentin Ananu Vreju Consultant for: abbvie and novartis, Speakers bureau: abbvie, novartis, pfizer, sandoz, eli lilly, ucb pharma, Garifallia Sakellariou: None declared, George Bruyn : None declared, Georgios Filippou Speakers bureau: Laborest, Abbvie, BMS, Sanofi, Giuliana M.C. La Paglia : None declared, Gustavo Leon: None declared, Helen Keen: None declared, Hilde Berner Hammer Grant/research support from: AbbVie, Pfizer and Roche, Paid instructor for: AbbVie, Pfizer, UCB, Novartis, Roche, Speakers bureau: AbbVie, Pfizer, UCB, Novartis, Roche, Ilaria Tinazzi: None declared, Irene Azzolin: None declared, Jacek Flicinski: None declared, James Wilton: None declared, Kei Ikeda: None declared, Lene Terslev Speakers bureau: Speakers fee from : Roche, Novartis, Pfizer, MSD, BMS, Celgene, Mads Ammitzboll-Danielsen: None declared, Mads Nyhuus Bendix Rasch: None declared, Marcin Milchert: None declared, Maria Stoenoiu Grant/research support from: Abbvie, Roche, Wyeth, Marion Kortekaas: None declared, Marwin Gutierrez: None declared, Mihaela Maruseac: None declared, Mohammed A Mortada: None declared, Philippe Carron: None declared, Rositsa Karalilova: None declared, Ruth Wittoek: None declared, Sarah Ohrndorf: None declared, Takeshi Suzuki: None declared, Teodora Serban: None declared, Maria-Antonietta d’Agostino: None declared, Andrew Filer: None declared" @default.
• W2949585417 created "2019-06-27" @default.
• W2949585417 creator A5003367359 @default.
• W2949585417 creator A5003660554 @default.
• W2949585417 creator A5006082336 @default.
• W2949585417 creator A5006938075 @default.
• W2949585417 creator A5013864738 @default.
• W2949585417 creator A5016980312 @default.
• W2949585417 creator A5020450271 @default.
• W2949585417 creator A5024158561 @default.
• W2949585417 creator A5027107889 @default.
• W2949585417 creator A5032563375 @default.
• W2949585417 creator A5037747961 @default.
• W2949585417 creator A5038835038 @default.
• W2949585417 creator A5040824148 @default.
• W2949585417 creator A5040878801 @default.
• W2949585417 creator A5044711512 @default.
• W2949585417 creator A5046382872 @default.
• W2949585417 creator A5047260745 @default.
• W2949585417 creator A5048382747 @default.
• W2949585417 creator A5051526033 @default.
• W2949585417 creator A5052584081 @default.
• W2949585417 creator A5053036587 @default.
• W2949585417 creator A5054073726 @default.
• W2949585417 creator A5055700950 @default.
• W2949585417 creator A5057441594 @default.
• W2949585417 creator A5059056208 @default.
• W2949585417 creator A5063791584 @default.
• W2949585417 creator A5064128395 @default.
• W2949585417 creator A5065029398 @default.
• W2949585417 creator A5067656420 @default.
• W2949585417 creator A5069576317 @default.
• W2949585417 creator A5072495554 @default.
• W2949585417 creator A5072897343 @default.
• W2949585417 creator A5074077824 @default.
• W2949585417 creator A5074177680 @default.
• W2949585417 creator A5075848283 @default.
• W2949585417 creator A5078727612 @default.
• W2949585417 creator A5081332555 @default.
• W2949585417 creator A5083838326 @default.
• W2949585417 creator A5085007794 @default.
• W2949585417 creator A5085037270 @default.
• W2949585417 creator A5090540043 @default.
• W2949585417 date "2019-06-01" @default.
• W2949585417 modified "2023-10-15" @default.
• W2949585417 title "THU0621 VERY LOW PREVALENCE OF ULTRASOUND DETERMINED TENDON ABNORMALITIES IN HEALTHY SUBJECTS THROUGHOUT THE AGE RANGE: OMERACT ULTRASOUND MINIMAL DISEASE STUDY" @default.
• W2949585417 doi "https://doi.org/10.1136/annrheumdis-2019-eular.4746" @default.
• W2949585417 hasPublicationYear "2019" @default.
• W2949585417 type Work @default.
• W2949585417 sameAs 2949585417 @default.
• W2949585417 citedByCount "4" @default.
• W2949585417 countsByYear W29495854172019 @default.
• W2949585417 countsByYear W29495854172020 @default.
• W2949585417 countsByYear W29495854172021 @default.
• W2949585417 crossrefType "proceedings-article" @default.
• W2949585417 hasAuthorship W2949585417A5003367359 @default.
• W2949585417 hasAuthorship W2949585417A5003660554 @default.
• W2949585417 hasAuthorship W2949585417A5006082336 @default.
• W2949585417 hasAuthorship W2949585417A5006938075 @default.
• W2949585417 hasAuthorship W2949585417A5013864738 @default.
• W2949585417 hasAuthorship W2949585417A5016980312 @default.
• W2949585417 hasAuthorship W2949585417A5020450271 @default.
• W2949585417 hasAuthorship W2949585417A5024158561 @default.
• W2949585417 hasAuthorship W2949585417A5027107889 @default.
• W2949585417 hasAuthorship W2949585417A5032563375 @default.
• W2949585417 hasAuthorship W2949585417A5037747961 @default.
• W2949585417 hasAuthorship W2949585417A5038835038 @default.
• W2949585417 hasAuthorship W2949585417A5040824148 @default.
• W2949585417 hasAuthorship W2949585417A5040878801 @default.
• W2949585417 hasAuthorship W2949585417A5044711512 @default.
• W2949585417 hasAuthorship W2949585417A5046382872 @default.
• W2949585417 hasAuthorship W2949585417A5047260745 @default.
• W2949585417 hasAuthorship W2949585417A5048382747 @default.
• W2949585417 hasAuthorship W2949585417A5051526033 @default.
• W2949585417 hasAuthorship W2949585417A5052584081 @default.
• W2949585417 hasAuthorship W2949585417A5053036587 @default.
• W2949585417 hasAuthorship W2949585417A5054073726 @default.
• W2949585417 hasAuthorship W2949585417A5055700950 @default.
• W2949585417 hasAuthorship W2949585417A5057441594 @default.
• W2949585417 hasAuthorship W2949585417A5059056208 @default.
• W2949585417 hasAuthorship W2949585417A5063791584 @default.
• W2949585417 hasAuthorship W2949585417A5064128395 @default.
• W2949585417 hasAuthorship W2949585417A5065029398 @default.
• W2949585417 hasAuthorship W2949585417A5067656420 @default.
• W2949585417 hasAuthorship W2949585417A5069576317 @default.
• W2949585417 hasAuthorship W2949585417A5072495554 @default.
• W2949585417 hasAuthorship W2949585417A5072897343 @default.
• W2949585417 hasAuthorship W2949585417A5074077824 @default.
• W2949585417 hasAuthorship W2949585417A5074177680 @default.
• W2949585417 hasAuthorship W2949585417A5075848283 @default.
• W2949585417 hasAuthorship W2949585417A5078727612 @default.
• W2949585417 hasAuthorship W2949585417A5081332555 @default.
• W2949585417 hasAuthorship W2949585417A5083838326 @default.
• W2949585417 hasAuthorship W2949585417A5085007794 @default.
• W2949585417 hasAuthorship W2949585417A5085037270 @default.
• W2949585417 hasAuthorship W2949585417A5090540043 @default.
• W2949585417 hasBestOaLocation W29495854171 @default.
• W2949585417 hasConcept C126322002 @default.
• W2949585417 hasConcept C126838900 @default.
• W2949585417 hasConcept C141071460 @default.

• next